Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsRadiation InjuriesRadiation DosageNeoplasmsRadiation, IonizingCombined Modality TherapyDose-Response Relationship, RadiationDrug Screening Assays, AntitumorCell Line, TumorRadiotherapyRadiation ToleranceDrug Resistance, NeoplasmRadiotherapy DosageChemotherapy, AdjuvantDoxorubicinCisplatinRadiationBreast NeoplasmsRadiation OncologyRadiation ProtectionApoptosisRadiotherapy, ConformalTreatment OutcomeRadiotherapy, Intensity-ModulatedRadiation MonitoringRadiotherapy, AdjuvantCell SurvivalDrug Delivery SystemsDose FractionationAntineoplastic Agents, PhytogenicLung NeoplasmsMice, NudeXenograft Model Antitumor AssaysProstatic NeoplasmsRadiotherapy Planning, Computer-AssistedRadiation PneumonitisEtoposideNeoplasm StagingDrug DesignNeoplasm Recurrence, LocalPaclitaxelSurvival AnalysisAntibiotics, AntineoplasticCell ProliferationRadiation-Sensitizing AgentsDisease-Free SurvivalTumor Cells, CulturedDrug DiscoveryMolecular Targeted TherapyNeoplasms, Radiation-InducedSurvival RateBrachytherapyBrain NeoplasmsClinical Trials as TopicTime FactorsPrognosisDrug CarriersGene Expression Regulation, NeoplasticDrug Resistance, MultipleDose-Response Relationship, DrugRadiometryCyclophosphamideHead and Neck NeoplasmsGamma RaysCarcinoma, Squamous CellAdenocarcinomaInhibitory Concentration 50Radiation Injuries, ExperimentalRadiosurgeryDNA DamageFollow-Up StudiesCamptothecinP-GlycoproteinCranial IrradiationNeoplasm MetastasisAntimetabolites, AntineoplasticColonic NeoplasmsMolecular StructureOvarian NeoplasmsCarcinoma, Non-Small-Cell LungCell CycleVinblastineCosmic RadiationNeoplasm ProteinsFluorouracilDrug Administration ScheduleDrugs, InvestigationalTumor BurdenMedical OncologyRadiotherapy, Computer-AssistedOrganoplatinum CompoundsBleomycinAntineoplastic Agents, AlkylatingCarboplatinNeoadjuvant TherapyDrug ApprovalEnzyme InhibitorsRetrospective StudiesTumor Markers, Biological